(Q39744334)

English

KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Maroulio Talieri

object named as

Maroulio Talieri

2

0 references

Konstantinos Mavridis

object named as

Konstantinos Mavridis

1

0 references

Andreas Scorilas

object named as

Andreas Scorilas

3

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

391

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

467-474

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Screening for prostate cancer: an update

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Cancer invasion and metastasis: changing views.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Chemotherapy for prostate cancer: finally an advance!

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Therapeutic options for hormone-refractory prostate cancer in 2007.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Emerging therapies in castrate-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progres

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Kallikrein-related peptidases

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Human tissue kallikrein gene family: applications in cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

The kallikrein world: an update on the human tissue kallikreins

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Advances in prostate cancer chemotherapy: a new era begins.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Molecular markers for prostate cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Androgen receptor and prostate cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Analyzing real-time PCR data by the comparative C(T) method

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Functional roles of human kallikrein-related peptidases

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Integrative biology of prostate cancer progression

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.026

21 January 2018

Identifiers

10.1515/BC.2010.026

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39744334&oldid=2089268936"